Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention
- 25 November 2019
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 156 (1), 140-146
- https://doi.org/10.1016/j.ygyno.2019.11.005
Abstract
No abstract availableKeywords
Funding Information
- Washington University School of Medicine in St. Louis
This publication has 22 references indexed in Scilit:
- National Estimates of Genetic Testing in Women With a History of Breast or Ovarian CancerJournal of Clinical Oncology, 2017
- Prevalence and Penetrance of Major Genes and Polygenes for Colorectal CancerCancer Epidemiology, Biomarkers & Prevention, 2017
- Evolving Paradigms in Research and Care in Ovarian CancersObstetrics & Gynecology, 2016
- Inherited Mutations in Women With Ovarian CarcinomaJAMA Oncology, 2016
- Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panelCancer, 2014
- Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the BahamasClinical Genetics, 2014
- Identification of Lynch Syndrome Among Patients With Colorectal CancerJAMA, 2012
- Characteristics of Health Information Gatherers, Disseminators, and Blockers Within Families at Risk of Hereditary Cancer: Implications for Family Health Communication InterventionsAmerican Journal of Public Health, 2009
- Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective StudyJournal of Clinical Oncology, 2008
- Factors Determining Dissemination of Results and Uptake of Genetic Testing in Families with Known BRCA1/2 MutationsGenetic Testing, 2008